When there is an excess of growth hormone or metabolic disorders, levels of IGFBP1 decrease, potentially resulting in severe physiological phenomena such as abdominal spasms, gastrointestinal bloat, and diarrhea (60). Here, GH1 is linked to metabolic disease.